12
Participants
Start Date
February 1, 2022
Primary Completion Date
November 25, 2024
Study Completion Date
November 25, 2024
Pegcetacoplan
20-cc glass vials-1080 mg
"General Hospital of Athens Evangelismos", Athens
"University General Hospital Attikon", Athens
Big Metropolitan Hospital Niguarda Regional Health Authority, Milan
ASST Monza - S. Gerardo Hospital, Monza
University Hospital Puerta de Hierro Majadahonda, Madrid
CHU de Saint-Etienne, Saint-Priest-en-Jarez
Mayo Clinic - Rochester, Rochester
"General Hospital of Thessaloniki G. Papanikolaou, Hematology Department - BMT Unit", Thessaloniki
Saint-Louis Hospital, Paris
Hospital San Giuseppe Moscati, Avellino
City of Hope, Duarte
United Hospitals Villa Sofia Cervello, Palermo
Archet 1 hospital, Department of Clinical Hematology, Nice
"University Polyclinic Foundation Agostino Gemelli - IRCCS", Roma
Lead Sponsor
Collaborators (1)
Apellis Pharmaceuticals, Inc.
INDUSTRY
Swedish Orphan Biovitrum
INDUSTRY